Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer
Clinical trial NCT00793546 · TERMINATED
Trial details
- NCT number
- NCT00793546
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-06-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.